Pages that link to "Q31921949"
Jump to navigation
Jump to search
The following pages link to The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells (Q31921949):
Displaying 50 items.
- Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis (Q24541529) (← links)
- PPARs and the cardiovascular system (Q24642728) (← links)
- Glutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferator-activated receptor gamma in human skeletal muscle cells (Q24655291) (← links)
- Activation of the peroxisome proliferator-activated receptor alpha protects against myocardial ischaemic injury and improves endothelial vasodilatation (Q24806958) (← links)
- PPAR-γ -- a possible drug target for complicated pregnancies (Q26863678) (← links)
- Role of lipotoxicity in endothelial dysfunction (Q27000731) (← links)
- Commonalities in the Association between PPARG and Vitamin D Related with Obesity and Carcinogenesis (Q28070220) (← links)
- Aspirin and PPAR-alpha activators inhibit monocyte chemoattractant protein-1 expression induced by high glucose concentration in human endothelial cells (Q28196404) (← links)
- Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a review (Q28220294) (← links)
- Association of the CYBA, PPARGC1A, PPARG3, and PPARD gene variants with coronary artery disease and metabolic risk factors of coronary atherosclerosis in a Russian population (Q28283856) (← links)
- Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidence (Q28393187) (← links)
- Effects of Ranolazine on Astrocytes and Neurons in Primary Culture (Q28550579) (← links)
- The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury (Q33561725) (← links)
- Endothelial and vascular muscle PPARgamma in arterial pressure regulation: lessons from genetic interference and deficiency. (Q33642053) (← links)
- Peroxisome Proliferator-Activated Receptors Protect against Apoptosis via 14-3-3 (Q34123741) (← links)
- Lack of PPARα exacerbates lipopolysaccharide-induced liver toxicity through STAT1 inflammatory signaling and increased oxidative/nitrosative stress (Q34664393) (← links)
- Protective effect of the combinations of glycyrrhizic, ferulic and cinnamic acid pretreatment on myocardial ischemia-reperfusion injury in rats (Q34795810) (← links)
- The role of PPARs in atherosclerosis (Q34838209) (← links)
- Protecting against vascular disease in brain (Q34979773) (← links)
- Pioglitazone restores phagocyte mitochondrial oxidants and bactericidal capacity in chronic granulomatous disease. (Q35090974) (← links)
- The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria (Q35101529) (← links)
- The role of oxidative stress and NADPH oxidase in cerebrovascular disease (Q35118380) (← links)
- Localization of peroxisome proliferator-activated receptor alpha (PPARα) and N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) in cells expressing the Ca(2+)-binding proteins calbindin, calretinin, and parvalbumin in the adult rat hippocamp (Q35132611) (← links)
- Relaxin causes selective outward remodeling of brain parenchymal arterioles via activation of peroxisome proliferator-activated receptor-γ. (Q35169517) (← links)
- Peroxisome proliferator-activated receptors and the cardiovascular system (Q35173859) (← links)
- Vascular NAD(P)H oxidases: specific features, expression, and regulation (Q35175526) (← links)
- Consequences of PPAR(α) Invalidation on Glutathione Synthesis: Interactions with Dietary Fatty Acids. (Q35208556) (← links)
- The central role of fat and effect of peroxisome proliferator-activated receptor-gamma on progression of insulin resistance and cardiovascular disease (Q35212543) (← links)
- Cystathionine beta synthase gene dose dependent vascular remodeling in murine model of hyperhomocysteinemia (Q35220296) (← links)
- Implications of Oxidative Stress and Homocysteine in the Pathophysiology of Essential Hypertension (Q35542924) (← links)
- Homocysteine and Essential Hypertension (Q35582716) (← links)
- Trials of antidiabetic drugs in amyotrophic lateral sclerosis: proceed with caution? (Q35618724) (← links)
- Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism. (Q35750111) (← links)
- The integration of lipid-sensing and anti-inflammatory effects: how the PPARs play a role in metabolic balance (Q35855689) (← links)
- The role of peroxisome proliferator-activated receptors in pulmonary vascular disease (Q35925357) (← links)
- Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone (Q35989215) (← links)
- Peroxisome proliferator-activated receptor-γ protects against vascular aging (Q35994295) (← links)
- Cellular mechanisms and treatment of diabetes vascular complications converge on reactive oxygen species (Q36062252) (← links)
- PPARalpha in atherosclerosis and inflammation (Q36154953) (← links)
- Regulation of ROS production and vascular function by carbon monoxide (Q36183868) (← links)
- Effect of troglitazone on radiation sensitivity in cervix cancer cells. (Q36195948) (← links)
- Pleiotropic effects of fibrates (Q36232396) (← links)
- Regulation of antioxidant and oxidant enzymes in vascular cells and implications for vascular disease (Q36442599) (← links)
- PPAR Agonists and Cardiovascular Disease in Diabetes (Q36444975) (← links)
- Interference with PPARγ in endothelium accelerates angiotensin II-induced endothelial dysfunction (Q36510633) (← links)
- Age-associated molecular changes in the kidney in aged mice (Q36530225) (← links)
- Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases? (Q36591722) (← links)
- Interference with PPARgamma signaling causes cerebral vascular dysfunction, hypertrophy, and remodeling. (Q36692337) (← links)
- Conjugated linoleic acid modulation of risk factors associated with atherosclerosis (Q36897274) (← links)
- Peroxisome-proliferator-activated receptors regulate redox signaling in the cardiovascular system (Q36952106) (← links)